Ocular manifestations of vasculitis

Rheumatic Disease Clinics of North America

Volumn 27, Issue 4, 2001, Pages 761-779

  Thorne, Jennifer E ^a,b   Jabs, Douglas A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYANOACRYLATE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

BEHCET DISEASE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EYE DISEASE; GIANT CELL ARTERITIS; HUMAN; KERATITIS; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RETINITIS; REVIEW; SCLERITIS; SYSTEMIC VASCULITIS; UVEITIS; WEGENER GRANULOMATOSIS;

EID: 0035163589     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70234-9     Document Type: Article

References (63)

1. Long-lasting remission of Behçet's disease after chlorambucil therapy
2. Retinal vasculitis
3. Visual prognosis in giant cell arteritis
4. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy
5. Neuro-ophthalmologic manifestations of rheumatologic and associated disorders
6. Allergic granulomatosis and angiitis (Churg-Strauss Syndrome): Report and analysis of 30 cases
7. The ocular manifestations of Behçet's disease
8. Necrotizing vasculitis
9. Iridocyclitis in two patients with hypocomplementemic vasculitis
10. Basic pattern of tissue damage and pathology of systemic lupus erythematosus
11. Immunosuppressives in uveitis: A preliminary report of experience with chlorambucil
12. Cyclophosphamide induced remissions in advanced polyarteritis nodosa
13. Cyclophosphamide therapy of severe systemic necrotizing vasculitis
14. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
15. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: Effects of systemic immunosuppression
16. Takayasu's arteritis: Frequency of systemic manifestations (study of 22 patients) and favorable response to maintenance steroid therapy with adrenocorticosteroids (12 patients)
17. Systemic associations of scleritis
18. Wegener's granulomatosis
19. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature
20. Ocular manifestations of giant cell arteritis
21. Wegener's granulomatosis: An analysis of 158 patients
22. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: Comparison in a prospective study
23. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease)
24. Ocular manifestations of the rheumatic diseases
25. Rheumatic diseases
26. Episcleritis and scleritis: Clinical features and treatment results
27. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
28. Small-vessel vasculitis
29. Giant cell arteritis: Signs and symptoms
30. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide
31. The rate of visual loss in Behçet's disease
32. Behçet's disease: A report of 28 cases
33. Double-masked trial of cyclosporine versus colchicine and long-term open study of cyclosporin in Behçet's disease
34. Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis
35. Posterior scleritis: Clinical features, systemic associations, and outcomes in a large series of patients
36. Conjunctival inflammation and amyloidosis in allergic granulomatosis and angiitis (Churg-Strauss Syndrome)
37. Fundus lesions in rheumatoid arthritis
38. Reversal of blindness in temporal arteritis with methylprednisolone
39. Inflammatory diseases of the peripheral cornea
40. Systemic lupus erythematosus and the eye
41. Effectiveness of cyclosporin therapy for Behçet's disease
42. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease
43. Ocular involvement in the respiratory vasculitides
44. Treatment of temporal arteritis with ocular involvement
45. An analysis of therapeutic decision for scleritis
46. Scleritis associated with rheumatoid arthritis and with ocular systemic immune-mediated diseases
47. Scleritis associated with systemic vasculitic diseases
48. Scleritis-associated uveitis
49. Severity of scleritis and episcleritis
50. The visual prognosis in temporal arteritis
51. Takayasu's arteritis and its therapy
52. Peripheral ulcerative keratitis and collagen vascular disease
53. Diagnostic and therapeutic approach to patients with retinal vasculitis
54. Systemic associations of retinal vasculitis
55. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis
56. Clinical features and associated systemic diseases of HLA-B27 uveitis
57. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease
58. Progression of scleral disease
59. Episcleritis and scleritis
60. Churg-Strauss syndrome (allergic granulomatous angiitis). Neuro-ophthalmology manifestations
61. A controlled trial of azathioprine in Behçet's syndrome